INSIGHTS ON DRUG DEVELOPMENT

  • 3 Key Considerations In Gene Therapy Manufacturing
    7/15/2025

    Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.

  • ddPCR Workflows For Gene Expression Analysis
    3/5/2026

    RT-ddPCR offers a powerful, flexible approach to precise RNA quantification. Learn how one-step and two-step workflows improve sensitivity and efficiency in your gene expression studies.

  • Biocatalysis 101: Faster, Greener API Manufacturing
    4/20/2026

    View how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support scalable, sustainable processes under mild conditions.

  • Facts About AAV Producer Cell Lines
    8/8/2025

    Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.

  • Calcium Carbonate As TiO2 Alternative In Coating
    11/7/2025

    Explore how calcium carbonate can replace titanium dioxide in tablet coating, as well as learn formulation strategies and review color performance data to support high-quality finishes in applications.

DRUG DEVELOPMENT SOLUTIONS

  • Standalone instrument with touchscreen and built-in sample ports for small volumes and cuvettes

    The SpectraMax® QuickDrop™ Micro-Volume Spectrophotometer quantifies very small amounts of DNA, RNA, oligos, and proteins.

  • Leica DM6 B Upright Microscope

    Increase your work efficiency with the Leica DM4 B or Leica DM6 B upright digital research microscopes! Both are ideally suited to making your work life easier in biomedical research and clinical labs alike.

    • Simplify your workflow with automated functions and easy-to-use software
    • Easily capture publication-quality images by utilizing the 19-mm sCMOS camera imaging port
    • Create fast overviews of your samples and identify the important details instantly with the LAS X Navigator Software
    • Have great flexibility through the choice of accessories
  • Observe how comprehensive R&D support advances therapeutic oligonucleotides from discovery through commercialization with tailored formulation development services across multiple modalities and delivery platforms.

  • Cambrex holds US Drug Enforcement Agency (DEA) licenses for process research, development, manufacturing, and importation of Schedule I to IV controlled substances.

  • When it comes to solid dosage formulations, the most common challenge formulators face is poor solubility. In numbers: 70% of drugs in development are poorly soluble.